持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/03/23 | 4,700 | 4,700 | 4,575 | 4,575 | -120 | -2.6% | 30,700 |
| 2021/03/22 | 4,620 | 4,725 | 4,595 | 4,695 | +45 | +1% | 56,600 |
| 2021/03/19 | 4,665 | 4,665 | 4,615 | 4,650 | -5 | -0.1% | 84,600 |
| 2021/03/18 | 4,705 | 4,720 | 4,610 | 4,655 | -40 | -0.9% | 57,700 |
| 2021/03/17 | 4,610 | 4,705 | 4,610 | 4,695 | +55 | +1.2% | 46,200 |
| 2021/03/16 | 4,530 | 4,645 | 4,515 | 4,640 | +140 | +3.1% | 79,800 |
| 2021/03/15 | 4,405 | 4,505 | 4,405 | 4,500 | +145 | +3.3% | 57,600 |
| 2021/03/12 | 4,370 | 4,395 | 4,335 | 4,355 | -60 | -1.4% | 79,500 |
| 2021/03/11 | 4,310 | 4,415 | 4,300 | 4,415 | +95 | +2.2% | 59,300 |
| 2021/03/10 | 4,290 | 4,355 | 4,270 | 4,320 | +15 | +0.3% | 51,300 |
| 2021/03/09 | 4,220 | 4,305 | 4,190 | 4,305 | +155 | +3.7% | 73,500 |
| 2021/03/08 | 4,150 | 4,175 | 4,115 | 4,150 | +10 | +0.2% | 42,900 |
| 2021/03/05 | 4,090 | 4,140 | 4,060 | 4,140 | +70 | +1.7% | 48,000 |
| 2021/03/04 | 4,035 | 4,080 | 4,030 | 4,070 | -5 | -0.1% | 31,800 |
| 2021/03/03 | 4,030 | 4,075 | 4,000 | 4,075 | +60 | +1.5% | 46,000 |
| 2021/03/02 | 4,005 | 4,030 | 3,965 | 4,015 | +10 | +0.2% | 65,800 |
| 2021/03/01 | 4,000 | 4,025 | 3,975 | 4,005 | +45 | +1.1% | 49,300 |
| 2021/02/26 | 4,060 | 4,070 | 3,960 | 3,960 | -110 | -2.7% | 63,800 |
| 2021/02/25 | 4,125 | 4,125 | 4,060 | 4,070 | -10 | -0.2% | 33,600 |
| 2021/02/24 | 4,115 | 4,155 | 4,070 | 4,080 | -65 | -1.6% | 50,200 |
| 2021/02/22 | 4,180 | 4,200 | 4,120 | 4,145 | -15 | -0.4% | 21,300 |
| 2021/02/19 | 4,205 | 4,235 | 4,160 | 4,160 | -60 | -1.4% | 32,500 |
| 2021/02/18 | 4,205 | 4,260 | 4,205 | 4,220 | +20 | +0.5% | 35,400 |
| 2021/02/17 | 4,255 | 4,255 | 4,200 | 4,200 | -55 | -1.3% | 17,900 |
| 2021/02/16 | 4,270 | 4,270 | 4,225 | 4,255 | +20 | +0.5% | 28,300 |
| 2021/02/15 | 4,275 | 4,275 | 4,220 | 4,235 | -25 | -0.6% | 32,700 |
| 2021/02/12 | 4,225 | 4,295 | 4,220 | 4,260 | +40 | +0.9% | 32,500 |
| 2021/02/10 | 4,195 | 4,250 | 4,165 | 4,220 | +25 | +0.6% | 36,200 |
| 2021/02/09 | 4,235 | 4,260 | 4,175 | 4,195 | -70 | -1.6% | 44,000 |
| 2021/02/08 | 4,110 | 4,275 | 4,070 | 4,265 | +185 | +4.5% | 104,800 |
| 2021/02/05 | 3,965 | 4,105 | 3,925 | 4,080 | +135 | +3.4% | 101,300 |
| 2021/02/04 | 3,930 | 3,965 | 3,915 | 3,945 | -10 | -0.3% | 19,200 |
| 2021/02/03 | 3,930 | 3,955 | 3,905 | 3,955 | +5 | +0.1% | 21,900 |
| 2021/02/02 | 3,975 | 4,010 | 3,930 | 3,950 | -20 | -0.5% | 37,100 |
| 2021/02/01 | 3,925 | 4,005 | 3,920 | 3,970 | +45 | +1.1% | 47,500 |
| 2021/01/29 | 3,970 | 4,025 | 3,925 | 3,925 | -45 | -1.1% | 33,300 |
| 2021/01/28 | 3,975 | 4,010 | 3,945 | 3,970 | -45 | -1.1% | 57,900 |
| 2021/01/27 | 3,955 | 4,015 | 3,945 | 4,015 | +70 | +1.8% | 38,900 |
| 2021/01/26 | 3,905 | 3,955 | 3,905 | 3,945 | +40 | +1% | 26,500 |
| 2021/01/25 | 3,905 | 3,915 | 3,880 | 3,905 | +25 | +0.6% | 21,200 |
| 2021/01/22 | 3,905 | 3,940 | 3,875 | 3,880 | -80 | -2% | 28,500 |
| 2021/01/21 | 3,900 | 3,985 | 3,895 | 3,960 | +65 | +1.7% | 47,300 |
| 2021/01/20 | 3,875 | 3,905 | 3,845 | 3,895 | +15 | +0.4% | 37,000 |
| 2021/01/19 | 3,950 | 3,950 | 3,880 | 3,880 | -65 | -1.6% | 25,100 |
| 2021/01/18 | 3,965 | 3,985 | 3,900 | 3,945 | -35 | -0.9% | 12,300 |
| 2021/01/15 | 4,005 | 4,010 | 3,975 | 3,980 | -10 | -0.3% | 30,000 |
| 2021/01/14 | 3,945 | 4,000 | 3,940 | 3,990 | +5 | +0.1% | 31,300 |
| 2021/01/13 | 3,975 | 3,995 | 3,935 | 3,985 | -20 | -0.5% | 28,100 |
| 2021/01/12 | 3,950 | 4,015 | 3,945 | 4,005 | +60 | +1.5% | 28,100 |
| 2021/01/08 | 3,875 | 3,945 | 3,850 | 3,945 | +75 | +1.9% | 33,500 |
901～
950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
